We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 17

WHO issues global alert on new strain of avian influenza (H7N9)

  • Shook Hardy & Bacon LLP
  • -
  • China, Global, USA
  • -
  • April 12 2013

The World Health Organization (WHO) has issued a global alert and response update on a new strain of novel avian influenza A (H7N9) virus identified

International telemedicine: 4 key considerations to launching a global telemedicine program

  • Epstein Becker Green
  • -
  • Global, USA
  • -
  • October 9 2012

All indications are that international telemedicine is well positioned for strong growth over the next several years

No causal link on cell phone cancer risk

  • Epstein Becker Green
  • -
  • Global, USA
  • -
  • June 10 2011

Consumer Reports, among others, reported this week that the International Agency for Research on Cancer ("IARC"), which is part of the World Health Organization ("WHO"), has classified low-level radiation from cell phones as "possibly carcinogenic to humans" based on limited evidence linking cell phone use to glioma, a type of brain cancer

Pharmaceutical mergers clear U.S. and international competition agencies with divestitures

  • Hogan Lovells
  • -
  • Global, USA
  • -
  • December 2 2010

Two recent transactions in the pharmaceutical space were scrutinized by various international competition agencies

Celebrity endorsements blamed for kids’ “junk” food choices

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • March 15 2013

A University of Liverpool study contends that "celebrity endorsement of a food product encourages children to eat more of the endorsed product." The

5 - 5.5 growth projected for the global pharmaceutical market

  • Gowling Lafleur Henderson LLP
  • -
  • Global, USA
  • -
  • January 19 2009

According to the National Association of Pharmaceutical Representatives (NAPRx), the global pharmaceutical market is expect to exceed $820 billion in 2009 growing by 4.5 - 5.5 percent

Free trade zones facilitate counterfeit drug trade

  • Gowling Lafleur Henderson LLP
  • -
  • Global, United Arab Emirates, USA
  • -
  • December 20 2007

A set of articles by investigative reporter Walt Bogdanich published in the New York Times and the International Herald Tribune on December 17, 2007 describe how international free trade zones such as those in the United Arab Emirates, Jordan, Mauritius and Panama are easing the passage of counterfeit drugs

Swine flu pandemic preparedness

  • Hunton & Williams LLP
  • -
  • Global, USA
  • -
  • April 27 2009

A "pandemic" requires four factors

FDA enters agreement to support WHO with counterfeit drug efforts

  • Reed Smith LLP
  • -
  • Global, USA
  • -
  • October 15 2010

The Food and Drug Administration (FDA) has entered into a collaborative agreement with the World Health Organization (WHO) in an effort to support the development of a global surveillance and monitoring system for combating counterfeit medicines and breaches in the supply chain

Trade negotiators seek comment on elimination of pharmaceutical import duties

  • Sidley Austin LLP
  • -
  • Global, USA
  • -
  • April 23 2010

Over 9,000 pharmaceutical and chemical intermediates enjoy duty-free treatment under the customs regime of the United States and other countries that participate in the World Trade Organization (WTO) Pharmaceutical Agreement

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy